Measurement of neurite outgrowth is a common assay of neurotrophic activity. However, currently available techniques for measuring neurite outgrowth are either time or resource intensive. The authors established a system in which chronic treatment of a subcloned SH-SY5Y cell line with aphidicolin and various concentrations of nerve growth factor (NGF) induced discernable alterations in proliferation and differentiation. Cells were fixed, labeled with a nonfluorescent dye, and evaluated both manually and with an automated analysis system. NGF increased multiple parameters of differentiation, including neurite length, the proportion of cells extending neurites, and branching, as well as promoting cellular survival/proliferation. Interestingly, although NGF treatment increased the total number of branches, it actually decreased the proportion of branches per neurite length. The authors observed no differences in results obtained using the manual and automated systems, but the automated system was orders of magnitude faster. To demonstrate the flexibility of the system, the authors also show that they could measure changes in differentiation induced by a small-molecule Rho kinase inhibitor, as well as by retinoic acid cotreatment with brain-derived neurotrophic factor. In addition to this flexibility, this system does not require specialized equipment or fluorescent antibodies for analysis and therefore provides a less resource-intensive alternative to fluorescencebased systems. (Journal of Biomolecular Screening 2006:155-164) Key words: nerve growth factor, image analysis, SH-SY5Y neuroblastoma, neurotrophins, Rho kinase inhibitor
INTRODUCTION
N ERVE GROWTH FACTOR (NGF), brain-derived neurotrophic factor (BDNF), and other members of the neurotrophin family are critical for the survival and differentiation of neurons within the peripheral and central nervous systems. Although the therapeutic potential of neurotrophins has generated much excitement in the past decade, inconvenient pharmacokinetics (necessity of injection and poor brain permeability), as well as nonspecific effects and toxicity, has limited the clinical usefulness of systemic application of neurotrophic factors. 1 Compounds that mimic neurotrophin signaling and overcome these other barriers might show greater therapeutic potential. 2 The ability of neurotrophins to induce neurite outgrowth in culture is the hallmark assay for assessing neurotrophic activity. 3, 4 Similarly, small-molecule mimetics of neurotrophins would also be assessed by their ability to induce neurite outgrowth. However, manual analysis of neurites is slow, time-consuming, and impractical for screening. Although there are commercially available sys-tems for automated neurite screens, these systems require significant financial resources both to obtain and to use (e.g., consumption of fluorescent antibodies). [5] [6] [7] We therefore sought to establish and validate an automated neurite analysis system that would be faster than manual methods but with similar sensitivity for detecting treatment effects.
MATERIALS AND METHODS

Chemicals
Dulbecco's Modified Eagle's Medium (DMEM) was purchased from GIBCO. Murine NGF was purchased from Promega (Madison, WI). Aphidicolin was purchased from Sigma (St. Louis, MO). Recombinant human BDNF was purchased from Peprotech EC (London, UK). Retinoic acid was purchased from Biomol (Plymouth Meeting, PA); Wf-536 was synthesized at Fujisawa Pharmaceutical Co. Ltd. (now Astellas Pharma Inc., Osaka, Japan). sponse to NGF in systems in which cells are manually selected, 8 we found that the response rate of these cells (i.e., typically 20%-30% of cells extended neurites longer than the cell body; data not shown) was too low for use in an automated assay. We therefore subcloned SH-SY5Y cells and selected a clonal cell line that showed an enhanced neurite outgrowth response to NGF (SH-08 clonal cells 9 ). SH-O8 cells were plated onto 24-well plates (BD Falcon Primaria™ plates; Benton-Dickson, Franklin Lakes, NJ) at 1.5 × 10 4 cells/well. The next day, cells were treated with 0.4 µM aphidicolin (in DMEM/10% fetal bovine serum/1% penicillin/ streptomycin by volume) for 5 days. Treatment of cells with aphidicolin was particularly important in achieving a low cell count because this DNA polymerase inhibitor decreases cell proliferation. [10] [11] [12] Cells were then treated with 5 concentrations of NGF (0.01-100 ng/mL) and maintained in media containing 0.4 µM aphidicolin. Media were replaced at 48 h after NGF addition, and neurite length was measured 48 h later (i.e., 96 h after initial treatment with NGF). This system uses relatively low cell density, which simplifies measurement by allowing long neurites to form without contacting other cells, combined with continuous aphidicolin treatment, which produces synergistic differentiation when combined with NGF (data not shown 10, 11, 13 ), providing a convenient system for measuring changes in NGF-induced neurite outgrowth. Rho inhibitor experiments were performed in the same manner, except that the Rho inhibitor Wf-536 14 (0.1-1000 nM) was substituted for NGF. For BDNF experiments, cells were treated as above, except that 10 µM retinoic acid (RA) was used instead of aphidicolin, and RA was present only during the first 5 days (i.e., RA was not cotreated with BDNF). Aphidicolin stocks (4 mM) and RA stocks were prepared in DMSO; NGF and BDNF stocks were prepared in DMEM at 100 µg/mL. Wf-536 (10 mM) was prepared in methanol.
Cell fixation and labeling
Cells were fixed in 4% paraformaldehyde in phosphatebuffered saline (PBS) for 1 h, rinsed once with PBS, and then stained with SimplyBlue SafeStain (Invitrogen, Carlsbad, CA) overnight. Cells were washed twice with PBS before image acquisition. This staining procedure stains the entire cell, including neurites, dark blue, allowing for high-contrast images to be produced ( Fig. 1) . Furthermore, this staining is stable for at least 3 months (data not shown) and requires no special handling, allowing preparation of multiple plates simultaneously for later analysis.
Automated image capture and analysis
Bright-field images were acquired on a Nikon inverted microscope (20× objective) with a Nikon digital camera (DXM-1200; Kanagawa, Japan). Plate movement and focus control were performed on an automated microscope stage (Prior Scientific, Rockland, MA) controlled by image acquisition software (Stage-Pro; Media Cybernetics, Silver Springs, MD). Three focus planes (Z-planes) were captured, and software autofocus was used to maximize the local contrast in each field. Treatment conditions were performed in quadruplicate (i.e., in 4 wells), and 30 discrete fields (715 µm × 572 µm) were obtained per well, resulting in more than 200 cells/condition being analyzed per experiment.
Automated image analysis was performed offline using a customized algorithm (Advansoft Inc., Osaka, Japan) running in ImagePro Plus 4.1 (Media Cybernetics, Silver Springs, MD). This algorithm first performs a series of preprocessing steps to isolate and identify neurite material. These steps include texture transformations, spatial filtering, morphological refinement, and image skeletonization to create a binary image. This final binary image is then reapplied as a mask to the original image to define relevant features for measurement. Manual image analysis was performed on the same images using WinRoof software (Mitani Corporation, Fukui, Japan).
Statistical analysis
Statistical analysis was performed using 2-way ANOVA for evaluation of treatment effects (e.g., NGF concentration or analysis method) and interactions. The Bartlett test was used to test for equal variances. Linear slopes were calculated based on standard linear regression, and slopes were compared by analysis of covariance. NGF dose-response data were analyzed using 1-way ANOVA with the Dunnett posttest. These tests were all conducted using GraphPad Prism, version 4.01 (GraphPad Software, San Diego, CA). Power analysis was conducted using Piface, version 1.61 (available at http://www.stat.uiowa.edu/~rlenth/Power/). A pvalue less than 0.05 was set as the level of significance.
RESULTS
Measurement of cell number
NGF has been shown to promote cellular proliferation in SH-SY5Y cells. 5, 15 To characterize the proliferative response of this subclonal SH-SY5Y line to NGF, we counted the number of cells per field in wells treated with aphidicolin alone or aphidicolin plus NGF (0.01-100 ng/mL). Cell treatment conditions were optimized so that most fields had at least 1 cell suitable for measurement ( Fig.  1) . Both manual and automated image analyses measured a dosedependent effect of NGF on cell number ( Fig. 2A) , although this effect did not reach statistical significance in this subset of images, F(5, 148) = 1.91, p < 0.1. Cell count values from both systems correlated ( Fig. 2B) , and there was not a significant difference between automated and manual scoring, interaction F(5, 148) = 0.07, p > 0.9. Automated scoring tended to overestimate the absolute number of cells, usually because of inappropriate background/ debris identification as a cell (Fig. 2C) .
Measurement of neurite length
Visual microscopic examination indicated that increasing concentrations of NGF produced multiple morphologic effects, most noticeably neurite elongation. Both manual and automated image analyses measured a dose-dependent effect of NGF on neurite length, F(5, 194) = 9.03, p < 0.0001, although they showed a difference in magnitude of about 1.5-fold ( Fig. 3A) . However, length values from both systems correlated (with an offset slope due to differences in absolute values; Fig. 3B ), and there was not a significant difference between automated and manual scoring in quantifying the response; that is, there was no difference in automated or machine response direction or magnitude across treatment conditions, interaction F(5, 194) = 1.53, p > 0.15. Postanalysis inspection of images in which manual and automated scoring did not correlate revealed that automated scoring tended to fail to measure the entire neurite length, particularly if intermediate or terminal segments were of lower contrast ( Fig. 3C) . There was no difference in the variance of the results, indicating similar precision of both methods at all NGF concentrations (Bartlett test, p > 0.9).
Measurement of other neurite outgrowth parameters
Having established that the automated system could correctly identify cells and neurites, as well as measure 1 parameter of the extent of neurite outgrowth (neurite length), we then wanted to determine optimum imaging parameters for this system (e.g., the number of photographs per condition). We also wanted to develop measurements of the initiation of neurite outgrowth 16 (percentage of cells with neurites >200 µm) and the complexity of outgrowth 17 (number of end points per neurite). NGF dose-dependently and consistently induced cellular differentiation, as measured by neurite outgrowth (Fig. 4A) , the percentage of cells with long neurites (Fig. 4B) , and the number of neurite end points ( Fig. 4C) , as well as induced cellular proliferation ( Fig. 4D) .
NGF treatment changes the proportion of branches versus neurite length
We next examined the effect of NGF on the relationship of neurite end points to neurite length, measured as the slope of the best-fit line for end points versus neurite length for each treatment condition (Fig. 5) . NGF treatment dose-dependently and significantly changed the slope of this line, indicating that NGF-treated neurites would have fewer branches than would untreated neurites of the same length, particularly for very long neurites.
Comparison of manual and automated systems
The automated system allows for more powerful analysis of differentiation parameters ( Table 1) . For example, the old system used 6-well plates in duplicate, totaling about 120 cells/ experiment. In contrast, this new system uses 24-well plates and generates data from a total of between 300 and 2000 cells/ condition. Furthermore, the previous system was subject to bias because cells for measurement were selected by the experimenter and represented the longest neurites in the well, or "best responders." This new system completely removes user bias because it measures all cells in a well and generates a population response. In addition, the data generated are much more rich and informative than merely neurite length, allowing increasingly sophisticated hypotheses to be generated and tested.
In addition to being more powerful, this system shows considerable improvements in speed (Table 1, bottom) . Previously, acquisition and analysis of photographs, combined with the time necessary to compile the data, required 2 to 3 h per condition (i.e., all cells for 1 control experiment). In contrast, the autostage system needs only about 5 min of human involvement to acquire and analyze photographs (although the actual time to do it is longer). Other improvements in data compilation dramatically reduced the time necessary for compilation, leading to a system that is 10-to 20-fold more efficient per condition.
Power analysis of neurite outgrowth parameters
To determine whether we had arrived at an optimum balance of time (image acquisition and analysis) and assay robustness, we conducted a power analysis. Power encompasses 2 ideas: 1) the probability that a statistical significance test will reject the null hypothesis for an alternative hypothesis, and 2) the ability of a test to detect an effect, given that the effect actually exists. An underpowered study will have indecisive results, even if the phenomenon is real, increasing the chances of missing an effect. Conversely, an overpowered study will likely produce very significant results, even if the magnitude of the effect is of little value. 18 Because we were primarily interested in designing an assay system for detecting changes in differentiation, we focused on these parameters for our analysis 19 ( Table 2) . This power analysis indicated that our conditions were suitable (i.e., not overpowered or underpowered) for an assay designed to detect meaningful changes in neurite outgrowth and differentiation.
Treatment with the small-molecule Rho kinase inhibitor Wf-536 induced differentiation
Rho kinases (ROCKs) are serine/threonine kinases that are important regulators of cell migration, cell proliferation, and cell survival. ROCK inhibition leads to neuronal differentiation, and ROCK inhibitors are effective in models of central nervous system injury (for review, see Mueller and others 20 ), suggesting that smallmolecule ROCK inhibitors might have significant therapeutic potential. We therefore tested whether the ROCK inhibitor, Wf-536, could induce measurable differentiation in our system. Under sim- ilar conditions as NGF, Wf-536 induced dose-dependent increases in neurite length (Fig. 6A) , the percentage of cells with long neurites (Fig. 6B) , and the number of end points per neurite (Fig.  6C) . In contrast to NGF, however, Wf-536 did not induce increases in cell number and actually significantly decreased it at the highest dose (Fig. 6D) . These results suggest that this system is applicable for small-molecule screening.
Cotreatment with RA and BDNF induced differentiation
We were also interested in whether our system could measure differentiation induced by other neurotrophic factors. Cotreatment with RA and BDNF induces differentiation in SH-SY5Y cells, 21 providing a convenient model for testing the capabilities of this system. It soon became clear, however, that there were significant differences in cellular morphology after treatment with aphidicolin (for NGF treatment, Figs. 1A, B ) and RA (for BDNF, Fig. 1D ). For example, NGF-treated cells do not undergo cell division (a consequence of aphidicolin treatment) and express 1 to 2 long neurites with minimal branching. Thus, measuring neurite length per cell is an appropriate end point. In the case of RA/BDNF treatment, however, cell division continues, and cells form a network of highly branched neurites (Fig. 1D) . RA-treated cells showed higher basal levels of differentiation than did aphidicolintreated cells (compare controls in Fig. 6 and Fig. 7) , and BDNF treatment significantly and potently induced changes in differentiation ( Fig. 7) . In fact, at the highest concentrations of BDNF, the network of neurites was so thick that multiple cells were often grouped as a single cell (Fig. 1D) , leading to an apparent decrease in cell number (Fig. 7D) . 
Nonfluorescent Automated Neurite Screening
DISCUSSION
Although the therapeutic potential of neurotrophins has generated much excitement in the past decade, inconvenient pharmacokinetics, as well as nonspecific effects and toxicity, has limited their clinical usefulness. Small-molecule mimetics or potentiators of neurotrophic signaling that overcome these barriers might show greater therapeutic potential. Cell-based assays that can identify compounds capable of mimicking the neurotrophic effects of neurotrophins under chronic conditions, while excluding compounds with toxicity or other undesirable characteristics, could be useful in accelerating such a drug-development program. We show that our system met these expectations in the experiments with Wf-536; those experiments demonstrated that the compound was cell permeable (because the molecular target, Rho, is an intracellular protein) and induced toxicity at the highest concentration tested, providing a preliminary indication of the compound's therapeutic window.
We describe here an automated system for analyzing neurite outgrowth that is orders of magnitude faster than manual methods but still accurately measures changes in proliferation and differentiation. Although the data did occasionally differ in absolute values from manually scored data (e.g., lower neurite length than with manual scoring), both automatic and manual data showed the same responses in both direction and magnitude to treatment condition; furthermore, there was no interaction between measurement method and neurite length. Because our purpose was to measure the same relative changes in neurite length with both systems, as opposed to the absolute magnitude of those changes, this system is suitable for this objective. In addition to a significant speed advantage over manual analysis, this system also has a number of advantages over commercially available neurite analysis systems, [5] [6] [7] including reduced resource use (both initially to purchase equipment and for continued use) and simple preparation of stable specimens. This system would also permit use of cells with fluorescent background (e.g., GFP-transfected cells). One limitation of our system is the inability to unambiguously identify and count individual cells. Although cell counting is easily performed by eye, automated counts are often inaccurate because cells tend to touch each other and blend together. The use of certain stains (e.g., nuclear), particularly in fluorescence-based systems, can overcome this limitation. In our system, though, the use of lower cell density, with many images acquired per condition, allows for accurate quantitation of cell number even without a nuclear or other counterstain, thus permitting a simple specimen-preparation technique. Although low cell density was acceptable for measuring NGF and Wf-536 activity, this requirement was somewhat limiting for BDNF (and possibly other differentiating pathways), where cell density was higher. Despite these limitations, however, combining this assay with traditional assays of cell number (e.g., MTT, thymidine incorporation) could differentiate between neuroprotective and proliferative effects.
Specifying a specific value for the throughput of a system is challenging and dependent on a number of factors. 22, 23 Image acquisition is the primary limiting factor in our system, with plate movement, autofocus, exposure, and camera readout accounting requiring about 2 h for a 24-well plate. This time requirement is in part due to 1) acquisition of high-resolution images (e.g., no binning) to improve image segmentation, 2) the use of softwarebased rather than hardware-based autofocusing, and 3) multiple field acquisitions (30 per well) to ensure adequate cell counts. Although reducing the number of fields per well would reduce acquisition time, our power analysis suggests that our imaging parameters were reasonable for detecting effects on neurite outgrowth. We are currently examining hardware autofocus options to speed up this process. In addition, we are exploring the use of higher-density plates (e.g., 48-or 96-well plates) to address this throughput limitation. Although image segmentation is also time-consuming (~5 s/image, 2 h/plate), the fact that it is completely automatic allows for 24-h offline analysis, equalizing acquisition and analysis throughput. Thus, this system is well suited for focused library screens or studies to determine the mechanism of action of interesting compounds. For example, we found that although NGF increased the total number of neurite end points, long neurites in NGF-treated cells tended to have fewer end points than did untreated neurites. Finally, the fact that we could measure differentiation downstream of multiple stimuli, including a small molecule and 2 different differentiation paradigms, suggests that our system possesses suitable generalizability, in addition to the above advantages. Thus, this system provides a platform for rapid, detailed analysis of differentiation and proliferation responses.
CONCLUSIONS
Although the correlation between neurite outgrowth and clinical/in vivo effects is not clearly established, the ability to identify compounds that promote neurite outgrowth in a similar fashion to established therapeutics (e.g., NGF) might overcome this obstacle. We therefore established an automated screening system that rapidly and accurately measured cellular proliferation and differentiation in response to multiple neurotrophic stimuli, suggesting that this system could perform as well as human scorers but with greater throughput. Automation of this assay provides a cellbased approach to rapidly identify novel neurotrophic compounds with significant therapeutic potential.
